|
DR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.99809946366258E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.2345013900017E-11 |
| Normal-vs-Stage2 |
9.96989999999531E-05 |
| Normal-vs-Stage3 |
6.060000E-03 |
| Normal-vs-Stage4 |
3.843200E-01 |
| Stage1-vs-Stage2 |
2.942800E-01 |
| Stage1-vs-Stage3 |
3.444400E-02 |
| Stage1-vs-Stage4 |
1.166800E-01 |
| Stage2-vs-Stage3 |
5.229600E-01 |
| Stage2-vs-Stage4 |
2.217400E-01 |
| Stage3-vs-Stage4 |
4.787000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.56700224912743E-11 |
| Normal-vs-AfricanAmerican |
9.5154000001596E-07 |
| Normal-vs-Asian |
4.507400E-01 |
| Caucasian-vs-AfricanAmerican |
1.658380E-01 |
| Caucasian-vs-Asian |
9.046400E-02 |
| AfricanAmerican-vs-Asian |
2.949800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.09248199165313E-12 |
| Normal-vs-Female |
1.980100E-04 |
| Male-vs-Female |
2.200200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.94239999990509E-07 |
| Normal-vs-Extreme_Weight |
6.70474786801378E-12 |
| Normal-vs-Obese |
6.13079999989274E-07 |
| Normal-vs-Extreme_Obese |
4.22260000000341E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.256200E-01 |
| Normal_Weight-vs-Obese |
6.098800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.245000E-01 |
| Extreme_Weight-vs-Obese |
4.260000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.135200E-01 |
| Obese-vs-Extreme_Obese |
5.025600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.285400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.45470002499826E-09 |
| Normal-vs-Age(61-80Yrs) |
9.90207915663177E-12 |
| Normal-vs-Age(81-100Yrs) |
3.76200004481575E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.835980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.241600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.949960E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.755700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.458800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.624100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63447033685316E-12 |
| Normal-VS-Type2 PRCC |
6.9975999994476E-08 |
| Normal-VS-KIRP CIMP |
5.855000E-01 |
| Normal-VS-Unclassified PRCC |
2.357900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.121700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.247690E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.332200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.109900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.931200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.052280E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.19060000641969E-09 |
| Normal-vs-N1 |
1.585210E-01 |
| Normal-vs-N2 |
7.211400E-01 |
| N0-vs-N1 |
3.251900E-02 |
| N0-vs-N2 |
6.828400E-02 |
| N1-vs-N2 |
8.320400E-01 |
|
|
